Int J Radiat Oncol Biol Phys 2006 Dec 1
Update of human spinal cord reirradiation tolerance based on additional data from 38 patients.
ABSTRACT
PURPOSE
To update a combined analysis of all published clinical data.
METHODS AND MATERIALS
We collected data from 38 additional patients treated in our department or published in four different reports and calculated the biologically effective dose (BED) according to the linear-quadratic model using an alpha/beta value of 2 Gy for cervical and thoracic cord and 4 Gy for lumbar cord. In this model, a dose of 50 Gy given in single daily fractions of 2 Gy is equivalent to a BED of 100 Gy(2) or 75 Gy(4).
RESULTS
The 2005 risk score based on three variables (cumulative BED, highest BED of all treatment series in a particular individual, and interval), which discriminate three different risk groups, does not require modification. The low-risk group now contains 1 case of radiation myelopathy (RM) after hypofractionated stereotactic reirradiation. Therefore, the rate increased from 0% to 3%. Intermediate-risk patients developed RM in 25%, and high-risk patients in 90%. When the interval between the two treatment courses is not shorter than 6 months and the dose of each course is < or =98 Gy(2), the cumulative BED where no case of RM has yet been reported is 120 Gy(2).
CONCLUSIONS
Based on these updated results, the risk of RM appears small after < or =135.5 Gy(2) when the interval is not shorter than 6 months and the dose of each course is < or =98 Gy(2). We would recommend limiting the dose to the lowest feasible level. The influence of very steep dose gradients from stereotactic and intensity-modulated approaches (i.e., a more complex volume-effect) requires further evaluation.
Related Questions
I'm aware of a number of publications that suggest that after 1-2 years, the cord should be able to handle about 50% of the original tolerance dose. &...
New answer by Radiation Oncologist at Yale School of Medicine (October 13, 2014)
Perhaps the most commonly used estimate is that the spinal cord “heals” 25% of the previously delivered dose six months after completing radiation. While this stat...
In a patient who received full dose to the spinal cord 10+ years prior, would SBRT be appropriate salvage therapy or is hyperfractionation prefer...
New comment by Radiation Oncologist at Indiana University Health ( May 21, 2020)
To piggyback on this, does anyone know if this was published? I am interested in reviewing but have not been able to find this series.
New comment by Radiation Oncologist at Fox Chase Cancer Center ( March 26, 2020)
I agree with @Christian Hyde's general points above, and I hesitate to comment on proton therapy, as I am not an expert. I certainly agree with the tenets of keeping the volum...
Do you have formal constraints and evaluate cumulative doses on the composite plan? Do you use traditional constraints but account for repair?
New answer by Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center (August 30, 2022)
I try to give full dose if treating for cure, e.g. 70 Gy. I like hyperfractionation as a way to separate the late and acute side effect curves, e.g., 72 Gy in 60 fx BID with c...